51 related articles for article (PubMed ID: 15991831)
1. Efficacy of atovaquone and sulfadiazine in the treatment of mice infected with Toxoplasma gondii strains isolated in Brazil.
Alves CF; Vitor RW
Parasite; 2005 Jun; 12(2):171-7. PubMed ID: 15991831
[TBL] [Abstract][Full Text] [Related]
2. Histopathological and ultrastructural assessment of atovaquone-proguanil hydrochloride combination in chronic murine toxoplasmosis.
Elmehankar MS; Elhenawy AA; Aboukamar WA; Elzoheiry MA; Nabih N
Ultrastruct Pathol; 2021 Nov; 45(6):376-383. PubMed ID: 34595988
[TBL] [Abstract][Full Text] [Related]
3. The High Potency of Green Synthesized Copper Nanoparticles to Prevent the Toxoplasma gondii Infection in Mice.
Albalawi AE; Alanazi AD; Alyousif MS; Sepahvand A; Ebrahimi K; Niazi M; Mahmoudvand H
Acta Parasitol; 2021 Dec; 66(4):1472-1479. PubMed ID: 34050875
[TBL] [Abstract][Full Text] [Related]
4. In vitro and in vivo susceptibility to sulfadiazine and pyrimethamine of Toxoplasma gondii strains isolated from Brazilian free wild birds.
de Lima Bessa G; Vitor RWA; Lobo LMS; Rêgo WMF; de Souza GCA; Lopes REN; Costa JGL; Martins-Duarte ES
Sci Rep; 2023 May; 13(1):7359. PubMed ID: 37147353
[TBL] [Abstract][Full Text] [Related]
5. Anti-Toxoplasma gondii effect of tylosin in vitro and in vivo.
Han RX; Jiang PC; Han B; Zhou HY; Wang YL; Guan JY; Liu ZR; He SY; Zhou CX
Parasit Vectors; 2024 Feb; 17(1):59. PubMed ID: 38341599
[TBL] [Abstract][Full Text] [Related]
6. In vitro activity of N-phenyl-1,10-phenanthroline-2-amines against tachyzoites and bradyzoites of Toxoplasma gondii.
Martins-Duarte ES; Portes JA; da Silva RB; Pires HS; Garden SJ; de Souza W
Bioorg Med Chem; 2021 Nov; 50():116467. PubMed ID: 34666274
[TBL] [Abstract][Full Text] [Related]
7. Antiparasitic agent atovaquone.
Baggish AL; Hill DR
Antimicrob Agents Chemother; 2002 May; 46(5):1163-73. PubMed ID: 11959541
[No Abstract] [Full Text] [Related]
8. MicroRNA mmu-miR-511-5p: A promising Diagnostic Biomarker in Experimental Toxoplasmosis Using Different Strains and Infective Doses in Mice with Different Immune States Before and After Treatment.
Mady RF; El-Temsahy MM; Issa YA; Zaghloul AS; Khedr SI
Acta Parasitol; 2024 Jun; 69(2):1253-1266. PubMed ID: 38743178
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of ursolic acid derivatives with potential anti-Toxoplasma gondii activity.
Zhang LH; Jin LL; Liu F; Jin C; Jin CM; Wei ZY
Exp Parasitol; 2020 Sep; 216():107935. PubMed ID: 32569599
[TBL] [Abstract][Full Text] [Related]
10. Anti-Toxoplasma In Vitro and In Vivo Activity of Pyrus boissieriana Arbutin-Rich Fraction.
Bahreini MS; Pourmohammadi SF; Gholami M; Habibollahi M; Pasdaran A; Hamedi A; Asgari Q
Acta Parasitol; 2024 Mar; 69(1):567-573. PubMed ID: 38231312
[TBL] [Abstract][Full Text] [Related]
11. Structure-activity relationships of
Alday PH; Nilsen A; Doggett JS
Expert Opin Drug Discov; 2022 Sep; 17(9):997-1011. PubMed ID: 35772172
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of
Węglińska L; Bekier A; Trotsko N; Kaproń B; Plech T; Dzitko K; Paneth A
J Enzyme Inhib Med Chem; 2022 Dec; 37(1):2621-2634. PubMed ID: 36165032
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of the effect of guanabenz-loaded nanoparticles on chronic toxoplasmosis in mice.
Abdelhamid Elgendy WM; Haggag YA; El-Nouby KA; El-Kowrany SI; El Marhoumy SM
Exp Parasitol; 2023 Mar; 246():108460. PubMed ID: 36642299
[TBL] [Abstract][Full Text] [Related]
14. Mefloquine loaded niosomes as a promising approach for the treatment of acute and chronic toxoplasmosis.
El Sharazly BM; Aboul Asaad IA; Yassen NA; El Maghraby GM; Carter WG; Mohamed DA; Amer BS; Ismail HIH
Acta Trop; 2023 Mar; 239():106810. PubMed ID: 36581225
[TBL] [Abstract][Full Text] [Related]
15. Sulfadiazine analogs: anti-Toxoplasma in vitro study of sulfonamide triazoles.
Arafa FM; Osman DH; Tolba MM; Rezki N; Aouad MR; Hagar M; Osman M; Said H
Parasitol Res; 2023 Oct; 122(10):2353-2365. PubMed ID: 37610452
[TBL] [Abstract][Full Text] [Related]
16. The Brazilian Toxoplasma gondii strain BRI caused greater inflammation and impairment in anxiogenic behavior in mice, which was reverted by rosuvastatin treatment.
Evangelista FF; de Laet Sant'Ana P; Ferreira WC; Ferreira TA; Dos Santos ML; de Souza AH; de Andrade FAL; da Silva DA; de Barros LD; Colli CM; Nogueira-Melo GA; Costa IN; Falavigna-Guilherme AL
Parasitol Res; 2023 Dec; 123(1):64. PubMed ID: 38117414
[TBL] [Abstract][Full Text] [Related]
17. Potential effects of alpha-pinene, a monoterpene commonly found in essential oils against
Kharazmkia A; Al-Abodi HR; Yadegari JG; Vahidi A; Mahmoudvand H
J Parasit Dis; 2022 Dec; 46(4):1055-1061. PubMed ID: 36457783
[TBL] [Abstract][Full Text] [Related]
18. Treatment of Murine Toxoplasmosis with Oral and Parenteral Artemether and Following by Detection of
Mikaeiloo H; Ghaffarifar F; Dalimi A; Zuhair Hassan M; Sharifi Z
Iran J Parasitol; 2022; 17(1):53-61. PubMed ID: 36046558
[TBL] [Abstract][Full Text] [Related]
19. Formulation and evaluation of atovaquone-loaded macrophage-derived exosomes against
Goudarzi F; Jajarmi V; Shojaee S; Mohebali M; Keshavarz H
Microbiol Spectr; 2024 Jan; 12(1):e0308023. PubMed ID: 38014940
[TBL] [Abstract][Full Text] [Related]
20. [Sulphadiazine crystaluria in a patient with disseminated toxoplasmosis].
de la Mata Navazo S; Butragueño Laiseca L; Slocker Barrio M; Mata Fernández A
An Pediatr (Engl Ed); 2020 Oct; 93(4):268-269. PubMed ID: 31761682
[No Abstract] [Full Text] [Related]
[Next] [New Search]
